IMM 13.2% 29.5¢ immutep limited

Ann: Immutep to present Phase IIb breast cancer data at ESMO 2022

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.